Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00722189 |
Recruitment Status
:
Completed
First Posted
: July 25, 2008
Last Update Posted
: March 19, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Skin Mycoses |
Study Type : | Observational |
Actual Enrollment : | 900 participants |
Time Perspective: | Prospective |
Official Title: | Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization |
Study Start Date : | July 2008 |
Actual Primary Completion Date : | January 2009 |
Actual Study Completion Date : | February 2009 |

Group/Cohort |
---|
A
All patients treated
|
- Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician [ Time Frame: Baseline to end of study ]
- Patient satisfaction [ Time Frame: Baseline to end of study ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Diagnosis of skin mycosis
Exclusion Criteria:
- Allergies to study medication

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00722189
Russian Federation | |
Kashkin Clinical Research Mycological Institute | |
St Petersburg, Russian Federation |
Study Director: | Bayer Study Director | Bayer |
Additional Information:
Responsible Party: | Bayer |
ClinicalTrials.gov Identifier: | NCT00722189 History of Changes |
Other Study ID Numbers: |
2008/01850 |
First Posted: | July 25, 2008 Key Record Dates |
Last Update Posted: | March 19, 2015 |
Last Verified: | March 2015 |
Keywords provided by Bayer:
Mycoses |
Additional relevant MeSH terms:
Mycoses Dermatomycoses Skin Diseases, Infectious Infection Skin Diseases |